Background illustration for clinical trials search

Paid Clinical Trials Phoenix

Discover 1,266 paid clinical trials in Phoenix, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Phoenix AZ, Sun City AZ, Tucson AZ, North Las Vegas NV,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: Sun City AZ, Scottsdale AZ, Newport Beach CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06588855

Phase3, Recruiting
FeaturedActive & Responsive

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

for
Metastatic Colorectal Cancer
Location: Phoenix AZ, Duarte CA, Los Angeles CA, Lone Tree CO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT04929223

Phase1, Recruiting
Featured

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Phoenix AZ, San Diego CA, Oceanside CA, Anaheim CA,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for
Breast Cancer
Location: Phoenix AZ, Goodyear AZ, San Marcos CA, La Jolla CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06790693

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

for
Alzheimers Disease
Location: Phoenix AZ, Imperial CA, Riverside CA, Albuquerque NM,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07170150

Phase3, Recruiting
Featured

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for
Alzheimers Disease
Location: Phoenix AZ, Sun City AZ, Imperial CA, Riverside CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase3, Recruiting
Featured

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

for
Juvenile Idiopathic Arthritis
Location: Phoenix AZ, Portland OR, Cincinnati OH,
Sponsor: AbbVie

Sex: All

Age: 1 - 17

Code: NCT05609630

Phase3, Recruiting
Featured

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

for
Ulcerative Colitis
Location: Phoenix AZ, San Diego CA, San Francisco CA, Dallas TX,
Sponsor: AbbVie

Sex: All

Age: 2 - 17

Code: NCT07071519

Phase3, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Phoenix AZ, Las Vegas NV, La Jolla CA, Albuquerque NM,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Glendale AZ, Sun City AZ, Chandler AZ, Tucson AZ,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase3, Recruiting
FeaturedNew

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: Phoenix AZ, Las Vegas NV, Rialto CA, Anaheim CA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase2, Recruiting
Featured

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for
Neovascular Age-related Macular Degeneration
Location: Sun City AZ, Mesa AZ, Poway CA, Redlands CA,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07007065

Phase3, Recruiting
FeaturedNew

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Scottsdale AZ, Spring Valley CA, Santa Ana CA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase2, Recruiting
Featured

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Glendale AZ, San Diego CA, Newport Beach CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase3, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Sun City AZ, Chandler AZ, Peoria AZ, Phoenix AZ,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase3, Recruiting
Featured

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

for
Diabetic Retinopathy
Location: Phoenix AZ, Scottsdale AZ, Poway CA, Durango CO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07592273

Phase2, Phase3, Recruiting
Featured

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

for
Advanced Prostate Cancer, Metastatic Prostate Cancer
Location: Scottsdale AZ, Vancouver, Nashville TX, Chicago IL,
Sponsor: Genentech, Inc.

Sex: Male

Age: 18+

Code: NCT05800665

Phase1, Recruiting
Featured

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

for
Advanced Prostate Cancer, Metastatic Prostate Cancer
Location: Scottsdale AZ, Nashville TN
Sponsor: Genentech, Inc.

Sex: Male

Age: 18+

Code: NCT07567846

Phase1, Phase2, Recruiting
Featured

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer
Location: Chandler AZ, Los Angeles CA, Oxnard CA, Ogden UT,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06568939

Phase2, Recruiting

With several prominent research institutions and a robust healthcare network, Phoenix stands out as a significant hub for clinical trials. The city hosts leading medical centers such as the Mayo Clinic’s Scottsdale campus, the Translational Genomics Research Institute (TGen), and the Arizona State University (ASU) Biomedical Engineering department. These institutions are at the forefront of advancing clinical research and innovation. The diverse population of Phoenix provides a broad participant base too, enhancing the accuracy and relevance of clinical studies.

Why choose Phoenix for clinical trials?

Phoenix offers distinctive advantages for those volunteering in clinical trials. The city's diverse and growing population provides a rich pool of participants, which enhances the accuracy and applicability of research outcomes.

Choosing to participate in a clinical trial in Phoenix allows individuals to contribute to critical medical advancements while benefiting from a supportive and well-established clinical research environment. The city's combination of a diverse participant base and cutting-edge research facilities makes it an ideal location for advancing medical science and improving healthcare outcomes.

Common conditions studied in Phoenix

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Phoenix